• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Healthcare·APMD
Share

Apnimed, Inc. Stocks

$ 16.4Last Updated 30.10.2026

Issuer Rating

Performance

Average

Risk

High

Recommendation

Sell

Market Cap

$ 722.50M

$ 16.4
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Favourable analyst view

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Latest news

31.07.2026 15:00

Apnimed IPO: Sleep apnea drug developer debuts on the Nasdaq

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

No company description

Target Price

Favourable
6/7
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

02.11.2026 11:34

U.S. Congressional Elections and Apple's Earnings Report: What Investors Can Expect This Week

01.11.2026 22:01

IPO roundup: Anthropic publishes prospectus, Blue Lagoon revives listing plans

31.10.2026 17:01

Small caps last week: Battle for Wendy’s, Brazil selloff, Innodata layoffs

31.10.2026 16:45

Fitch cuts France’s credit rating outlook ahead of fresh protests

31.10.2026 13:01

What Is Anthropic Hiding? Google Is "Eating" Itself, and Netflix Has Fallen Into Its Own Trap

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026